KCM
USNA icon

Kames Capital Management’s Usana Health Sciences USNA Stock Holding History

Kames Capital Management’s Portfolio USNA Stock Details USNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q2 		– Sell
-27,076
Closed -$1.02M – 175
2014
Q1 		$1.02M Sell
27,076
-18,592
-41% -$649K 0.03% 157
2013
Q4 		$1.73M Buy
+45,668
New +$1.75M 0.06% 124

Other funds holding USNA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Schroder Investment Management Group
Schroder Investment Management Group London, United Kingdom $122B AUM 29.27% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return

Kames Capital Management's USNA Position: Q2 2014 in Review

Kames Capital Management sold out of Usana Health Sciences (USNA) in Q2 2014, closing a stake of 27,076 shares — an estimated $1.02M sold.

Kames Capital Management first reported a position in USNA in Q4 2013 and held it in 2 quarters. The position peaked at $1.73M in Q4 2013. 123 funds tracked by Wall St. Rank hold USNA as of Q2 2014.

  • Kames Capital Management reported no remaining Usana Health Sciences position as of Q2 2014 after selling out during the quarter.
  • Kames Capital Management sold 27,076 Usana Health Sciences shares in Q2 2014, an estimated $1.02M.
  • Kames Capital Management first reported a position in Usana Health Sciences in Q4 2013 and held it in 2 quarters.
  • Kames Capital Management's Usana Health Sciences position peaked at $1.73M in Q4 2013.
  • 123 funds tracked by Wall St. Rank held Usana Health Sciences as of Q2 2014.

Based on Kames Capital Management's 13F filing for Q2 2014, filed 17 Jul 2014.